On the first day of the VPH2018 Conference in Zaragoza, the VPH Institute will host a special plenary session to present the research priorities for in silico medicine in Horizon Europe, the framework programme set to launch in 2021 that will succeed Horizon 2020.
The Commission has already published its proposal, which sees the ambitious allocation of €100 billion for the research and innovation programme. The proposal was made as part of the EU's proposal for the next EU long-term budget, the multiannual financial framework (MFF). Further details can be found here.
The session will be opened by the VPH Institute Executive Director, Prof Lies Geris, who will present the joint VPHi-Avicenna Alliance position paper on Horizon Europe. The position paper includes the recommendations of our community to revolutionise the current healthcare system thought the application of in silico models, so that the concept of the right treatment for the right patient at the right time would become standard practice.
The session will see the participation of both Violeta Isabel PĂ©rez Nueno, Programme Officer in charge of the in silico portfolio at Unit 3 - eHealth, Well-being & Ageing, DG CONNECT - European Commission, and Tina Morrison, Deputy Director of the Division of Applied Mechanics at the FDA, who will present the in silico medicine priorities in both side of the Atlantic.
Tentative agenda:
These presentations will be followed by a VPHi membership-only Information and Networking event on the Funding Opportunity for in silico Medicine in H2020"
